Myriad Announces New Favorable Coverage Policies for Prolaris® from Three New Commercial Health Plans Including Major National Provider


You May Also Like

Clementia Pharmaceuticals to Participate in Upcoming Investor Conferences

MONTREAL, Sept. 06, 2017 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ:CMTA), a clinical stage ...

TESARO Draws $200 Million From Second Tranche of Non-Dilutive Term Loan Financing

WALTHAM, Mass., June 29, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology focused ...